wugen

about

WUGEN IS DEVELOPING ITS NOVEL CAR-T PLATFORM TO BRIDGE THE GAPS IN CANCER THERAPIES

wugen inc.

WUGEN’S STATE-OF-THE-ART GENE EDITING TECHNOLOGIES ADDRESS THE CHALLENGES OF ALLOGENEIC CAR-T MANUFACTURING

 

WUGEN WAS FOUNDED ON TECHNOLOGY LICENSED FROM WASHINGTON UNIVERSITY IN ST. LOUIS